• Proceedings of the Korea Contents Association Conference
• /
• 2012.05a
• /
• pp.175-176
• /
• 2012

세포선별검사에서 ASCUS로 진단된 검체 중 F-UP이 진행되지 않은 검체 179건을 대상으로 HPV High risk factor, Low risk factor를 확인하기 위해서 Hybrid Capture II Test를 하였다. 결과 High risk factor 양성 및 Low risk factor 양성은 전체 179 cases 중 25 cases로 나타났으며, 전체 검체 중 약 15%에 해당되었다. 또한 전체 15%의 양성검체 중 High risk factor 양성은 87%에 해당되는 것을 확인하였다. 결론적으로 효과적인 검진 체계를 갖춘 나라에서도 자궁경부암의 예방이 완전히 해결되지 않고 있는 문제점이 있는 여건을 고려해 볼 때 추적 관찰이 용이하지 않은 경우를 대비해 자궁경부암으로 진행될 수 있는 precancerous lesion의 원인 인자인 HPV 존재 유무를 세포선별검사와 HPV Hybrid Capture II Test를 동시에 시행하는 것이 효과적이라고 사료된다.

• Biomedical Science Letters
• /
• v.4 no.2
• /
• pp.143-151
• /
• 1998

To study the incidence and epidemiological factors of uterine cervical cancer in medical underserved area females, the questionnaire survey and Pap. smear for uterine cervical cancer was done on total 330 women who lived in Ullungdo from 5th to 12th August, 1998. The results were summarized as follows： The age distribution of subjects was 50s (24.5%), 60s (24.5%) and their educational level was “no schooling” (14.2%) and “elementary school” (42.7%). The first coital age of subjects was 19∼21yrs (30.0%), 16∼18yrs (13.9%) and the first pregnancy age was 22∼24yrs (36.7%) and 19∼21yrs (30.0%). The frequency of total pregnancy of subjects was over 5 times (52.1%). The frequency of total delivery was “3∼4 times” (35.5％) and “5∼6 times” (15.2％). 68.8% of subjects had experience of abortion and 80.0% of their husband were on the phimosis. 172 (52.1%) subjects had gynecological symptoms, their symptoms were leukorrhea (48.3%), pruritus (21.5%) and leukorrhea with pruritus (20.3%). 63.9% of total subjects have been received Pap. smear and the frequency of their Pap. smear was “only 1 time” (44.1 ％), “irregularly” (30.3%) and the reason of respondents who have not been received Pap. smea. was “no specific symptom” (51.3%). Among the 330 women screened there were negative (45.8%), inflammation (47.3%), trichomoniasis and candidiasis (1.8%), atypical cells (4.5%) and dysplasia (0.6%).

• 대한예방의학회:학술대회논문집
• /
• 1998.10b
• /
• pp.97-98
• /
• 1998

• Radiation Oncology Journal
• /
• v.24 no.2
• /
• pp.123-127
• /
• 2006

Purpose: The purpose of this study was to investigate the clinical findings, treatment, and outcome of patients with glassy cell carcinoma of cervix. Materials and Methods: We reviewed all cases of glassy cell carcinoma of the uterine cervix confirmed and treated at the Dongsan Medical Center, Keimyung University, between January 1993 and December 2005. There were 7 cases with histopathologically confirmed gassy cell carcinoma. A tumor was diagnosed as glassy cell carcinoma if over 50% of the tumor cell type displayed glassy cell features. Six patients with stage IB had radical hysterectomy and bilateral pelvic node dissection, and 2 of them received adjuvant external pelvic irradiation with concurrent chemotherapy. Remaining one patient with stage IIA had curative concurrent chemoradiotherapy with external pelvic irradiation and brachytherapy. Results: There were 7 patients diagnosed as glassy cell carcinoma among the 3,745 (0.2%) patients of carcinoma of uterine cervix. The mean age of 7 patients was 44 years with range of 35 to 53 years of age. The most frequent symptom was vaginal bleeding (86%). By the punch biopsy undertaken before treatment of 7 cases, 2 only cases could diagnose as glassy cell carcinoma of uterine cervix, but remaining of them confirmed by surgical pathological examination. The mean follow up duration was 73 months with range of 13 to 150 months. All 7 patients were alive without disease after treatment. Conclusion: Glassy cell carcinoma of the uterine cervix is a distinct clinicopathologic entity that demonstrates an aggressive biologic behavior. However for early-stage disease, we may have more favorable clinical outcome with radical surgery followed by chemoradiothery.

• The Journal of the Korea Contents Association
• /
• v.13 no.8
• /
• pp.308-313
• /
• 2013

Among 179 specimen diagnosed with ASCUS but did not go through biopsy or other tests, 26 cases (14.52%) showed positivity in HPV Hybrid Capture II Test. There were 25 cases of HPV high risk factor(+), marking 13.96%, and 3 cases of low risk factor(+) at 1.67%. According to cytology manifestation, patients with over LSIL can increase their complete recovery rate with continuous tests, but most patients diagnosed ASCUS do not go through any tests at all. It is considered that in order to prevent and start early treatment on cervical cancer, the HPV Hybrid Capture II Test must be enforced to patients diagnosed with ASCUS. Negative patients should go through routine screening, and positive patients should receive treatment after colposcopy.

• Women's Health Nursing
• /
• v.16 no.3
• /
• pp.255-265
• /
• 2010

Purpose: This study's aim was to investigate participation in Pap smear screening among married immigrant women and their behavior and its related factors. Methods: A survey was conducted among 165 married immigrant women in Gyeongsangnam-do from January 1 to March 20, 2010. Results: Results in this study showed that 51.5% have never participated in Pap Smear screening. Among those who have participated in the Pap Smear screening, 10.9% had regular screening, while 37.6% had irregular screening. Pap smear screening behavior was significantly different according to the experiences in health checkup ($x^2$=34.009, p<.001)', whether or not there was a hospital the woman regularly visited ($x^2$=7.768, p=.021) and perceived barriers (F=3.214, p=.043). Conclusion: For improvement of Pap smear participation, this study proposes to develop various nursing intervention programs which can improve perceived barriers in regards to the related variables. In addition, it is necessary to come up with a strategy to advertise the participation in Pap smear screening in a systematic and continuous manner in order to raise womens' awareness and to make married immigrant women realize the importance of regular Pap smear screenings.

• Proceedings of the Korean Information Science Society Conference
• /
• 1999.10b
• /
• pp.533-535
• /
• 1999

자궁경부진 세포인식 시스템에 있어서 가장 중요한 것이 영상처리를 이용하여 세포핵과 세포질을 추출하여 세포의 형태적인 정보를 알아내는 과정이다. 기존의 전역 thresholding 기법이나 region growing의 경우는 pap smear 검사를 통해 얻어진 세포 영상을 분할할 수 있는 region growing 기법을 제안한다. 제안된 region growing 기법은 초기에 seed를 검출할 때 local threshold growing 기법을 제안한다. 제안된 region growing 기법은 초기에 seed를 검출할 때 local threshold 개념을 도입하여 seed의 검출을 고르게 하고, 2가지 확장 조건을 사용하여 영역을 확장한다. 첫 번째 확장 조건은 비정상 세포나 artifact가 많아서 어둡게 나타나는 영상이나 세포질과 배경의 경계가 뚜렷하지 않아서 세포질의 구별이 어려운 영상의 영역 분할이 가능하도록 그 특성을 반영하고, 두 번째 조건은 세포가 흡수하는 빛의 양이 일정하다는 가정으로 영상에서의 지역 특성(gray level, color 등을 반영한다. 제안된 기법은 정상세포 영상뿐만 아니라 비정상 세포 영상에 대하여 over-segment나 under-segment하는 경우를 줄여서 영역 분할에 좋은 결과를 보인다.

• 대한예방의학회:학술대회논문집
• /
• 1995.10a
• /
• pp.111-112
• /
• 1995

• Radiation Oncology Journal
• /
• v.18 no.4
• /
• pp.300-308
• /
• 2000

Purpose :The aim of this study is to analysis of suwival and recurrence rates of the uterine cervical carcinoma patients whom received the radiation therapy respectively. The prognostic factors, such as Papanicolaou (Pap) smear, carcinoembriogenic antigen (CEA) and squamous cell carcinoma (SCC) antigen has been studied. Methods and Materials : From January 1981 to December 1998, eight-hundred twenty-seven uterine carvical cancer patients were treat with radiation therapy. All of the patients were divided into two groups : the radiation therapy only (S2l patients) group and the postoperative radiation therapy (326 patients) group. The age, treatment modality, clinical stage, histopathology, recurrence, follow-up Pap smears, CEA and SCC antigen were used as parameters for the evaluation. The prognostic factors such as survival and recurrence rates were peformed with the Kaplan-Meier method and the Cox hazard model, respectively. Median rollow-up was 38.6 months. Results :On the radiation therapy only group, 314 patients (60$\%$) achieved complete response (CR), 47 patients (9$\%$) showed local recurrence (LR), 78 patients (15$\%$) developed distant metastasis (DM). On the Postoperative radiation therapy group, showed 276 Patients (85$\%$) CR, 8 Patients (2$\%$) LR, 37 Patients (11$\%$) DM. The 5-year survival and recurrence rates was evaluated for all parameters. The statistically significant factors for the survival rate in univariate analysis were clinical stage (p=0.0001), treatment modality (p=0.0010), recurrence (p=0.0001), Pap smear (p=0.0329), CEA (p=0.0001) and SCC antigen (p=0.0001). Conclusion: This study indicated that after treatment, the follow-up studies of Pap smear, CEA and SCC antigen were significant parameter and prediction factors for the survival and recurrence of the uterine cervical carcinoma.

• The Korean Journal of Cytopathology
• /
• v.13 no.1
• /
• pp.1-7
• /
• 2002

The significance of endometrial cells on cervicovaginal smears is underestimated. The aim of this study is to evaluate the detection rate of endometrial cells on cervicovaginal smears. The materials consisted of two groups. Group I was 701 cervicovaginal smears from patients with no gynecological problems. Group II was 208 cervicovaginal smears from patients with abnormal uterine bleeding followed by endometrial curettage; 31 cases of endometrial adenocarclnoma(CA), 19 cases of endometrial hyperplasia(HP), 83 cases of dysfunctional uterine bleeding(DUB), and 75 cases of normal endometrium. Cervicovaginal smears were reviewed according to the criteria of The Bethesda System. Endometrial cells were identified in 15 of 701 cases(2.1%) in group I and 64 of 208 cases(30.8%) in group II. Among group II, detection rate of endometrial cells was the highest in CA (51.6%) compared to HP(26.3%), DUB(41.0%), and normal endometrium(12.0%) (p<0.05). Cytologic atypia of endometrial cells was not found In group I, but was more frequently identified in CA(87.5%) than in HP(10.5%) or DUB(14.7%) (p<0.05). Exfollatlon of endometrial cells might be related to abnormal endometrial lesion, and reporting of endometrial cells in the cervicovaginal smear may increase a chance to detect endometrial lesions especially in patients with abnormal uterine bleeding.